Herbal hepatoprotective mixture in the treatment of chronic lymphocytic leukemia

Objective: to evaluate the effectiveness of herbal hepatoprotective mixture as an adjunct treatment in patients with chronic lymphocytic leukemia.

Material and methods: the study was based on an analysis of 42 patients with confirmed diagnosis of chronic lymphocytic leukemia, who were treated in the hematology department of the National Medical Center “Shifobakhsh”. The herbal blend was used in patients whose clinical course was accompanied by hepatomegaly. The study group included 30 patients (71.4%), and the control group included 12 patients (28.5%). Patients in the study group received an herbal infusion of medicinal plants described by the authors as hepatoprotective: Silybum marianum, birch, mint, and immortelle. The control group did not receive the infusion.

Results: use of the herbal hepatoprotective infusion was associated with a positive effect, namely a reduction and normalization of liver size within a short period. In the main group, a liver size reduction of 1.5 cm was recorded in 7 patients (23.3%), 1.2 cm in 19 patients (63.3%), and 1.0 cm in 4 patients (13.3%). A slower decrease in liver size was observed in the control group, which did not receive the infusion (0.7 to 0.8 cm).

Conclusion: use of an herbal hepatoprotective mixture as an adjunct to standard therapy improves treatment outcomes and reduces the time to recovery of liver function in patients with chronic lymphocytic leukemia. 

1. Bakhtina V.I., Demko I.V., Kravchenko S.K., Protopopova E.B. Chronic Lymphocytic Leukemia. Modern Problems of Science and Education. 2016;(3):54-61. (In Russ.).

2. Goryacheva S.R., Sorokina T.V., Al-Radi L.S., Sherstnev A.A., Moiseeva T.N. Possibilities of therapy for relapse of chronic lymphocytic leukemia complicated by autoimmune complications. Literature data and own observation. Onkogematologiya. 2018;(10):92-96. (In Russ).

3. Kayynbayeva A.K., Tulsuhanov S.T., Murzakhametova M.K., Utegalieva R.S., Aralbayeva A.N., et al. Hepatoprotective effect of a plant-based preparation in tetrachloromethane intoxication. Bulletin of KazNU. 2012;3(35):132-136. (In Russ).

4. Maev I.V., Samsonov A.A., Andreev D.N. Diseases of the Stomach. Monograph. Moscow. 2015. (In Russ).

5. Galchenko O.E., Morozova V.A., Babaeva A.R. Modern possibilities of using hepatoprotectors in the treatment of chronic diffuse liver diseases. Medicinal Bulletin. 2015(2):7-17. (In Russ).

6. Minushkin O.N., Zverkov I.V., Ostrovskaya A.I. Hepatoprotectors of plant origin. Medical Council. 2016(14):48-51. (In Russ).

7. Melnikova V.Yu., Urakov K.Z., Khodziyeva G.B. Clinical and functional and ultrasound characteristics of the liver and spleen in patients with chronic myeloid leukemia depending on the stage of the disease. Health Care of Tajikistan. 2015(3):74-79. (In Russ).

8. Nitin J., William G., Susan O. Cronic lymphocytic leukemia. The Lancet. 2024;404(10453):694-706.

9. Maksimov M.L., Shindina T.S., Kropova O.E. Hepatoprotective and infusion therapy for patients with inflammatory liver diseases. Medical Review. 2018;7(11):82-87.

10. Mekhtiev S.N., Berko O.M., Mekhtieva O.A. Rational choice of hepatoprotectors in the treatment of chronic liver diseases. Effective Pharmacotherapy. 2023;19(35):50-58.